Telmisartan-DRLA Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Telmisartan

Indications/Uses

Essential HTN in adults. Risk reduction of non-fatal stroke or MI in patients ≥55 yr at high risk of developing major CV events who cannot tolerate ACE inhibitors. High risk of CV events including CAD evidence, peripheral arterial disease, stroke, transient ischemic attack, DM w/ end-organ damage evidence.

Dosage/Direction for Use

Essential HTN 40 mg once daily. May increase dose to a max of 80 mg once daily in cases where target BP is not achieved. CV morbidity reduction 80 mg once daily. Mild to moderate hepatic impairment Max: 40 mg once daily.

Administration

May be taken with or without food: Swallow whole w/ liqd

Contraindications

Hypersensitivity. Biliary obstructive disorders. Concomitant use w/ aliskiren in patients w/ DM or renal impairment (GFR <60 mL/min/1.73 m²). Rare hereditary conditions that may be incompatible w/ an excipient. Severe hepatic impairment. Pregnancy (2nd & 3rd trimesters). Lactation.

MIMS Class

Angiotensin II Antagonists

ATC Classification

C09CA07 - telmisartan ; Belongs to the class of angiotensin II receptor blockers (ARBs). Used in the treatment of cardiovascular disease.

Regulatory Classification

POM

Presentation/Packing

Form

Telmisartan-DRLA tab 80 mg

Packing/Price

1's

Telmisartan-DRLA

telmisartan

Manufacturer:

Dr Reddy's Lab